Prevalence of electrocardiographic changes in Kemerovo region according to the data of the ESSE-RF study
O. M. Polikutina,
Yu. S. Slepynina,
V. N. Karetnikova,
T. A. Mulerova,
E. V. Indukaeva,
G. V. Artamonova https://doi.org/10.15829/1728-8800-2019-1-120-126
Abstract
Aim. To study the prevalence of ECG changes associated with gender and age according to the program ESSE-RF, Kemerovo.
Material and methods. The object of the study is a random sampling of male and female population aged 25-64, Kemerovo. The standard 12-leads ECG was captured in 1623 people. Coding was carried out according to the Minnesota code. The average age of the respondents was 49 years (37; 57), men, 47 years (36; 56), women, 50 years (38; 57), (p=0,004).
Results. The ECGs changes were recorded in 265 people (16,3%), in 124 men (17,8%) and 141 women (15,2%) (p=0,159). Heart rhythm disturbances were revealed in 108 people (6,7%), intraventricular conduction disturbances in 147 (9%). The most frequently recorded changes in the T wave (in 11,2% of the subjects), ST segment changes take the second place (in 5,1%), the pathological Q wave was registered less frequently (in 2,5%). In men, the ECG signs of LV hypertrophy, rhythm disturbances, the pathological Q wave were more often detected. In the group of the 50-64-year-olds, the pathological Q wave, changes in ST segment and T wave, rhythm and conduction disturbances were detected significantly more often as well as the greater prevalence of risk factors of ischemic heart disease.
Conclusion. Detection of ECG changes is an important stage in the formation of a risk group at the development and progression of the cardiovascular pathology.
About the Authors
O. M. Polikutina
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Kemerovo
Russian Federation
Kemerovo
Yu. S. Slepynina
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Kemerovo
Russian Federation
Kemerovo
V. N. Karetnikova
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Kemerovo
Russian Federation
Kemerovo
T. A. Mulerova
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Kemerovo
Russian Federation
Kemerovo
E. V. Indukaeva
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Kemerovo
Russian Federation
Kemerovo
G. V. Artamonova
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Kemerovo
Russian Federation
Kemerovo
References
1. Elffers TW, Mutsert R, Lamb HJ, et al. Association of metabolic syndrome and electrocardiographic markers of subclinical cardiovascular disease. Diabetology & Metabolic Syndrome. 2017;9:40. doi:10.1186/s13098-017-0238-9.
2. Soliman EZ, Backlund JC, Bebu I, et al. Electrocardiographic Abnormalities and Cardiovascular Disease Risk in Type 1 Diabetes: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care. 2017;40(6):793-9. doi:10.2337/dc16-2050.
3. De Bacquer D, De Backer G, Kornitzer M. Prevalence of ECG findings in large population based samples of men and women. Heart. 2000;84:625-33.
4. Boytsov SA, Chazov EI, Shlyakhto EV, et al. Scientific and the organizing Committee of the ESSERF. Epidemiology of cardiovascular diseases in different regions of Russia (ESSE-RF), rationale and study design. Profilakticheskaya Medicina. 2013;16(6):25-34. (In Russ.)
5. Prineas RJ, Crow RS, Zhang ZM. The Minnesota Code Manual of Electrocardiographic Findings (including measurement and comparison with the Novacode). Standards and Procedures for ECG Measurement in Epidemiologic and Clinical Trials. London: Springer, 2010. p. 328. doi: 10.1007/978-1-84882-778-3
6. Ashley EA, Raxwal V, Froelicher V. An evidence-based review of the resting electrocardiogram as a screening technique for heart disease. Progress in Cardiovascular Diseases. 2001;44(1):55-67. doi:10.1053/pcad.2001.24683.
7. De Bacquer D, De Backer G, Kornitzer M, et al. Prognostic value of ECG findings for total, cardiovascular disease, and coronary heart disease death in men and women. Heart. 1998;80:570-7.
8. Verdecchia P, Dovellini EV, Gorini M, et al. Comparison of electrocardiographic criteria for diagnosis of left ventricular hypertrophy in hypertension: the MAVI study. Ital Heart J. 2000;1(3):207-15.
9. Katholi RE, Couri DM. Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications. Int J Hypertens. 2011;2011:ID 495349 p 10. doi:10.4061/2011/495349.
10. Bauml MA, Underwood DA. Left ventricular hypertrophy: An overlooked cardiovascular risk factor. Cleveland Clinic J Med. 2010;77(6):381-7. doi:10.3949/ccjm.77a.09158.
11. Vinyoles E, Soldevila N, Torras J, et al Prognostic value of non-specific ST-T changes and left ventricular hypertrophy electrocardiographic criteria in hypertensive patients: 16-year follow-up results from the MINACOR cohort. BMC Cardiovascular Disorders. 2015;15:24. doi:10.1186/s12872-015-0012-6.
12. Bao H, Cai H, Zhao Y, et al. Nonspecific ST-T changes associated with unsatisfactory blood pressure control among adults with hypertension in China: Evidence from the CSPTT study. Medicine (Baltimore). 2017;96(13):e6423. doi:10.1097/MD.0000000000006423.
13. Wong ND, Detrano RC, Diamond G, et al. Does coronary artery screening by electron beam computed tomography motivate potentially beneficial lifestyle behaviors? Am J Cardiol. 1996;78:1220-3.
14. Sheifer SE, Manolio TA, Gersh BJ. Unrecognized myocardial infarction. Ann Intern Med. 2001;135:801-11.
15. Sigurdsson E, Thorgeirsson G, Sigvaldason H, Sigfusson N. Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris. The Reykjavik Study. Ann Intern Med. 1995;122:96-102.
16. Akimova EV, Gafarov VV, Trubacheva IA, et al. Coronary heart disease in Siberia: interpopulation differences. Sibirsky Meditsinsky Zhurnal. 2011;3(1):153-7. (In Russ.)
17. Muromtseva GA, Deev AD, Konstantinov VV, еt al. The Prevalence of Electrocardiographic Indicators among Men and Women of Older Ages in the Russian Federation. Rational Pharmacotherapy in Cardiology. 2016;12(6):711-7. (In Russ.) doi:10.20996/1819-6446-2016-12-6-711-717.
Review
For citations:
Polikutina O.M., Slepynina Yu.S., Karetnikova V.N., Mulerova T.A., Indukaeva E.V., Artamonova G.V. Prevalence of electrocardiographic changes in Kemerovo region according to the data of the ESSE-RF study. Cardiovascular Therapy and Prevention. 2019;18(1):120-126. (In Russ.) https://doi.org/10.15829/1728-8800-2019-1-120-126
Views:
825
Email this article 
